RESUMO
Polypharmacy and Neuroleptics in Swiss Nursing Homes in the Years 2019 and 2020 Abstract. We present data from 92404 clinical assessments from 619 Swiss nursing homes . The data were collected in 2019 and 2020 from over 65-year-old residents. Two-thirds of those studied had severe cognitive limitations, one quarter had significant behavioral disorders and just over half of the assessed patients showed signs of emotional instability or depression. 46% were treated with nine or more different drugs, 37% received a neuroleptic in 85% for more than 90 days. There is a positive correlation between the number of drugs taken, age, cognitive impairment and susceptibility to falls. Since neuroleptics are administered in 30% under uncertain indication and the susceptibility to falls is increased by 40% under neuroleptics, their use should be reduced in the course of structured interprofessional processes.
Assuntos
Antipsicóticos , Polimedicação , Idoso , Antipsicóticos/efeitos adversos , Humanos , Casas de Saúde , SuíçaRESUMO
The resident assessment instrument (RAI) as a standardized assessment has become established as the gold standard in homes for the elderly and resident nursing homes in Switzerland. The RAI is an important tool with respect to the clarification of needs in long-term outpatient and inpatient nursing care in compliance with the requirements of the Health Insurance Act. The information collated in the initial assessment, the minimum data set (MDS), can be reliably utilized for the nursing process and measurement of quality. The key to success in long-term inpatient nursing can be attributed to the generalized financial solution of resource utilization groups (RUG), which is generated directly from the assessment. Due to standardized training and documentation and in the inpatient area, a uniform electronic data processing solution, a vast amount of data from the last 15 years of experience are available also for scientific use.
